With the increasing development of new treatments for tumors based on AFP characteristics, in patent US20080318840A1, Pak demonstrated that AFP, after co-incubation with Atractyloside, Thapsigargin and Betulinic Acid, had a remarkable therapeutic effect on tumor cells, tumor-bearing mice, and cancer patients. The gene discussed is AFP; the disease is cancer.